✦ LIBER ✦

Increased serum levels of soluble CD95 (APO-1/Fas) in relapsing-remitting multiple sclerosis

✍ Scribed by Dr. Frauke Zipp; Michael Weller; Peter A. Calabresi; Joseph A. Frank; Craig N. Bash; Johannes Dichgans; Henry F. McFarland; Roland Martin

Publisher: John Wiley and Sons
Year: 1998
Tongue: English
Weight: 633 KB
Volume: 43
Category: Article
ISSN: 0364-5134
DOI: 10.1002/ana.410430120

No coin nor oath required. For personal study only.

✦ Synopsis

Nucleus-driven multiple large-scale deletions of the human mitochondrial genome: a new autosomal dominant disease. Am J Hum Genet 1990; 47:904-914 10. Moraes CT, Ciacci F, Bonilla E, et al. Two novel pathogenetic mitochondrial DNA mutations affecting organelle number and protein synthesis. Is the tRNALe"'uuR) gene an etiologic hot spot?

📜 SIMILAR VOLUMES

Levels of soluble fas/APO-1 /CD95 in sys

Levels of soluble fas/APO-1 /CD95 in systemic lupus erythematosus and juvenile rheumatoid arthritis

✍ Eckart Knipping; Peter H. Krammer; Karen B. Onel; Thomas J. A. Lehman; Eduardo M 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 304 KB 👁 2 views

To quantify soluble Fas/APO-1 (sFas/ APO-1) protein in the serum of patients with systemic lupus erythematosus (SLE) and juvenile rheumatoid arthritis (JRA). Methods. Soluble Fas/APO-1 was quantified using a sandwich enzyme-linked immunosorbent assay. Disease activity in SLE patients was assessed b